welcome to summit

Summit is an Oxford, UK based drug discovery company with a portfolio of partner funded drug programmes and an innovative Seglin™ technology platform for the discovery of new medicines.

promobox01_for_investors
Result of General Meeting

The Result of the General Meeting held on 20 April 2012 are available in the Investor Relations section.

Seglin technology drug discovery platform
Seglin

Our recently updated Seglin section provides more information about this innovative drug discovery platform.

our Programms 03
image

Visit our programmes section to find out more about our research activities and drug programmes.

current share price:

LSE (SUMM): 2.62p +0.00p
at closed   18 May 2012
15 minute delayed share price from London Stock Exchange provided by Hemscott Group Limited

latest news: